These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

736 related items for PubMed ID: 12341096

  • 1. [Contraception with pure, synthetic progestogens of the norpregnane group, a new approach for the future?].
    Rozenbaum H.
    Contracept Fertil Sex (Paris); 1986 Jun; 14(6):577-81. PubMed ID: 12341096
    [Abstract] [Full Text] [Related]

  • 2. [Ultrasonic and hormonal monitoring of the ovaries during mini-dose oral contraception].
    Doyen J, Schaaps JP, Lambotte R.
    Contracept Fertil Sex (Paris); 1987 May; 15(5):529-33. PubMed ID: 12268693
    [Abstract] [Full Text] [Related]

  • 3. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V.
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [Abstract] [Full Text] [Related]

  • 4. Progestogen contraception using chlormadinone acetate in women presenting high vascular risk. (A gynecoendocrine, metabolic and vascular study).
    Pelissier C, Basdevant A, Conard J, Egloff M, Husson T, Guyenne TT.
    Contracept Fertil Sex (Paris); 1987 Jan; 15(1):45-54. PubMed ID: 12315161
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Oral contraception and carbohydrate metabolism--the physiopathological explanation].
    Hilal M.
    Contracept Fertil Sex (Paris); 1985 Dec; 13(12):1213-7. PubMed ID: 12267513
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Contraception using normal dose progestins].
    Pelissier-langbort C.
    Contracept Fertil Sex (Paris); 1984 Oct; 12(10):1099-109. PubMed ID: 12266559
    [Abstract] [Full Text] [Related]

  • 11. [Macroprogestative contraception: advantages].
    Jamin C.
    Contracept Fertil Sex (Paris); 1993 Feb; 21(2):123-8. PubMed ID: 12318009
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
    Gaspard U, Dubois M.
    Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606
    [Abstract] [Full Text] [Related]

  • 14. [Effect of combined contraceptive tablets on blood levels of the gonadotropic hormones estradiol and progesterone (author's transl)].
    Balogh A, Ditroi F, Batar I, Lampe L.
    Orvoskepzes; 1981 Sep; 56(3):220-8. PubMed ID: 12338270
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Amenorrhea and the pill].
    Verdino P, Viard R, Harter M.
    Lyon Mediterr Med Med Sud Est; 1983 Jan; 19(2):7067-74. PubMed ID: 12279701
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Value of subcutaneous fat in predicting ovulation day.
    Jamaludin J, Nordin NM, Mohamad N, Etta KM.
    Malays J Reprod Health; 1988 Jun; 6(1):65-9. PubMed ID: 12281593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.